IFNG and neoplasm: Upon infection of tumor cells, G47Δ-mIL12 releases a significant amount of IL12 (14), a master regulator of antitumor immunity, that enhances activation of dendritic cells and T lymphocytes, induces IFN-γ production, and inhibits angiogenesis (17–19).